tradingkey.logo

Tempus AI rises on slightly lifting annual revenue forecast

ReutersAug 8, 2025 2:55 PM

Shares of genetics testing firm Tempus AI TEM.O rise 3.3% to $60.63

Company slightly raised its 2025 revenue forecast to $1.26 billion, from its previous projection of $1.25 billion

Company posts quarterly revenue of $314.6 million compared with $165.97 million a year ago

Says it saw significant re-acceleration of clinical volumes which grew 30% in the reported quarter, as co delivered more than 212,000 next-generation sequencing tests

Up to last close, stock up 38.8% YTD

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI